Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581227 · ClinicalTrials.gov registry record
The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 4,679
- Enrollment target
NCT03581227: Completed study, sponsored by Weill Medical College of Cornell University.
NCT03581227 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 4,679 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03581227 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 4,679 participants
- Enrollment target
Study Summary
A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad range of primary care settings.
Primary Outcome
Sensitivity and specificity of CAPTURE to identify previously undiagnosed patients with clinically significant COPD at baseline. Clinically significant COPD is defined as participants with abnormal spirometry, defined as post-bronchodilator FEV1/FVC \< 0.7, plus one of the following: FEV1 \< 60% predicted, or ≥ 1 exacerbation-like event within the past 12 months. If a participant is unable to complete a post-bronchodilator spirometry (refusal, technical error on the part of coordinator, etc.),
Interventions
- OTHER CAPTURE Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,679 participants |
| Start Date | 2018-10-12 |
| Est. Completion | 2022-04-01 |
What the finished NCT03581227 record still lists
NCT03581227 is an observational study that tracks outcomes without assigning an intervention. Its 4,679 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which CAPTURE Tool is the first listed.
NCT03581227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03581227 about?
NCT03581227 is a clinical study titled "The CAPTURE Study: Validating a Unique COPD Case Finding Tool in Primary Care (Aim 1)". A prospective multi-center study to define the sensitivity and specificity of CAPTURE for identifying previously undiagnosed patients with clinically significant COPD in a broad range of primary care settings.
What is the current status of trial NCT03581227?
This trial is currently completed. The enrollment target is 4,679 participants. The study started on 2018-10-12. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT03581227?
The interventions under investigation include: CAPTURE Tool (OTHER).
Who is sponsoring clinical trial NCT03581227?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- NCT06888388 · 4,700 participants
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI